datopotamab
Daiichi Sankyo,AstraZeneca
[]
great discussion by on sequencing adc after adc. clinical activity of adc past disease progression on adc still maintained though lower prospective trials ongoing to answer this question #asco23 
Breast oncologist, translational researcher @RoswellPark Tweets are my own and not medical advice.